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A B S T R A C T
Histoplasmosis is a systemic mycosis caused by Histoplasma capsulatum. Rare in Europe but endemic in some
regions of Brazil, United States, Africa and Asia. Most of the cases are asymptomatic. Disseminated form is
deﬁned by the presence of an extra-pulmonary focus, particularly associated with immunosuppression. We re-
port a case of an unilateral persisted tonsillar ulceration, in an immunocompetent Portuguese host, as mani-
festation of disseminated African histoplasmosis 45 years later after living 3 years in Africa.
1. Introduction
Histoplasmosis is a systemic mycosis caused by Histoplasma capsu-
latum, a dimorphic fungus, ﬁrst described in 1906 by Samuel Darling in
Panama [1,2]. It has been isolated from soil contaminated with bird or
bat droppings in endemic areas such as Brazil, North/Central of United
States, central/western Africa and parts of Asia; it´s rare in Europe and
frequently associated with patients from endemic areas who seek care
in Europe or visited those countries in the past [3–8]. There are two
varieties of H. capsulatum that are pathogenic to humans: H. capsulatum
var. capsulatum and H. var. capsulatum duboisii. Less common, H. cap-
sulatum var. duboisii is the etiologic cause for African histoplasmosis
[3,5]. In var. capsulatum, most of the cases are asymptomatic, and those
with symptoms usually present with self-limited respiratory infection.
Variety duboisii has tropism for lymph nodes, skin, and bones and is
classically associated with cutaneous lesions (nodules, ulcers) and os-
teolytic bone lesions, especially aﬀecting the skull, ribs, and vertebrae
[6]. The disseminated form is deﬁned by the presence of an extra-
pulmonary focus, particularly on those with risk factors: im-
munosuppression, transplantation, chronic renal disease, prolonged use
of corticosteroids and acquired immune deﬁciency syndrome [7,9]. One
third of disseminated disease presented oropharyngeal involvement.
The most common sites are tongue, palate and buccal mucosa [2]. We
report a rare case of a disseminated African histoplasmosis in an im-
munocompetent Portuguese host presented with unilateral tonsillar
ulceration and large inguinal lymphadenopathy 45 years after living in
Africa.
2. Case
A 68 years-old Caucasian Portuguese male, presented at day 0 in the
otorhinolaryngology emergency department with 2 months’ sore throat,
loss of weight (5 kg) and persisted tonsillitis after several treatments
with antibiotics. He denied other complaints such as cough, dyspnea,
nocturnal sweating, nausea, vomiting, diarrhea or headaches. Medical
history included alcohol and tobacco abuse stopped 15 years ago; re-
sidency on a rural area with daily contact with birds, cats and dogs;
malaria and typhoid fever during his ﬁrst year of military service in
Portuguese Colonial War in Africa (Angola) from 1969 to 1971; right
inguinal hernia since 2005.
At admission, on day 0, a complete exam revealed a left tonsillar
ulceration (Fig. 1A) with bilateral cervical infracentimetric lymphade-
nopathy and a 5 cm right inguinal lymphadenopathy, mobile and
nontender (Fig. 1B).
At day 0, routine hematological parameters were normal; blood and
urine cultures were sterile; c-reactive protein, erythrocyte sedimenta-
tion rate, serum levels of liver enzymes, bilirubin and lactate dehy-
drogenase were within reference ranges; serologic tests for human im-
munodeﬁciency virus (HIV), hepatitis B virus, hepatitis C virus, herpes
simplex virus, Borrelia burgdorferi, Brucella, Bartonella, Histoplasma and
interferon-gamma release assays were negative; previous contact/in-
fection and immunity – immunoglobulin (Ig) M negative and IgG po-
sitive – were documented to Chlamydia trachomatis, epstein-barr virus,
Chlamydophila pneumoniae, Cytomegalovirus, Toxoplasma and Varicella
zoster; routine serologic antibodies for autoimmune diseases were also
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negative. Screening test for syphilis was positive.
Chest X-ray, cervical/thoracic computed tomography (CT) and
upper gastrointestinal endoscopy were normal.
To exclude malignancy, on day 5, a biopsy of the ulcerated tissue
was performed and direct examination revealed large narrow based
budding yeast cells compatible with Histoplasma (Fig. 2). Culture of
ulcerated tissue on Sabouraud dextrose agar at 30 °C revealed a white
ﬁlamentous fungus one month after incubation (Fig. 3), the microscopic
examination with lacto-phenol cotton blue preparation, showed septate
hyphae and thick-walled tuberculated conidia. Genomic DNA was ex-
tracted and the internal transcribed spacer (ITS) region of ribosomal
DNA (rDNA) was ampliﬁed using primer set ITS1 (5′TCCGTAGGTGA-
ACCTGCGG3′) and ITS4 (5′TCCTCCGCTTATTGATATGC3′). The aligned
sequence was compared with sequences deposited at GenBank database
and showed> 98% similarity with H. capsulatum var. duboisii se-
quences, which is the value considered as an acceptable identiﬁcation
to species level. The isolate is deposited at GenBank database with the
accession number KY420902.
Left inguinal lymphadenopathy was removed on day 33 and histo-
pathologic study was positive for Periodic Acid Schiﬀ (PAS) and
Grocott's methenamine silver (GMS) stains and revealed ovoid yeast
cells in direct histopathologic exam also compatible with histo-
plasmosis.
Patient was treated with Benzathine penicillin G 7.2 million units
total, administered as 3 doses of 2.4 million units intramuscular each at
1-week intervals. After treatment, on day 30, Rapid Plasm Reagin for
Treponema pallidum were negative but the tonsillar ulceration persists.
On day 35, he started oral itraconazol 200 mg three-times-daily for the
ﬁrst 3 days and then 200 mg twice-daily for 12 months.
After 1 month of treatment, tonsillar ulceration healed completely
with some retraction of the soft palate (Fig. 4) and there was no cervical
lymphadenopathy palpable. Inguinal region also healed well. There was
no sign of disease or side eﬀects during the 12-month period of anti-
fungal treatment. Six months after treatment, no recurrence was also
detected.
3. Discussion
Oral ulcerations have many diﬀerent etiologies and it can be a
challenge to diagnose and manage. Their cause can range from minor
irritation to systemic diseases (viral, bacterial, fungal or autoimmune)
and malignancies. Malignancy must be excluded, particularly in solitary
persisted ulceration, in patients with history of alcohol and smoking
Fig. 1. A. Left tonsilar ulceracion; B. Right inguinal
lymphadenopathy.
Fig. 2. Histoplasma capsulatum var. duboisii yeast in fresh exam from tonsillar tissue
(400x).
Fig. 3. Septate, hyaline hyphae with large thick-walled spherical macroconidia.
Lactophenol cotton blue from the culture plate −400x.
Fig. 4. Oral cavity: 1 month after treatment.
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behavior. A biopsy is mandatory. Oral histoplasmosis is unusual and is
typically associated with immunosuppression status, especially in pa-
tients with AIDS and/or active pulmonary tuberculosis. Oral lesions can
be the presentation of disseminated disease.
There are several cases worldwide reported with oral histoplasmosis
in immunocompetent patients [7,9–19]. In Portugal, only one case was
published about an oral histoplasmosis in a hemodialysis patient with
persisted fever [9].
Our case illustrates a two-month persistent tonsillar ulceration as a
manifestation of disseminated African histoplasmosis in an im-
munocompetent Portuguese patient who lived three years in Africa
1969–1971) and had an inguinal lymphadenopathy misdiagnosed as
inguinal hernia for years. H. capsulatum var. duboisii is not endemic in
Europe and the patient might acquire the infection in Africa. This pa-
tient also had a positive screening for syphilis that mislead/delay the
diagnosis and treatment for histoplasmosis.
The deﬁnitive diagnosis of histoplasmosis requires isolation of the
H. capsulatum on speciﬁc culture media or visualization in direct ex-
amination using speciﬁc fungal staining techniques: PAS or GMS. Non-
culture methods have also been developed and include antibody or
antigen detection, although there is an increase in false-negative results
in the disseminated form of histoplasmosis [5]. In our patient, the im-
munodiﬀusion antibody detection was negative; in our experience this
method is less sensitive for detection of the Histoplama capsulatum du-
boisii.
Until the azole era began in the 1990s, amphotericin B deoxycholate
was the only therapeutic option. Nowadays, patients who are not se-
verely ill, can be treated with oral itraconazole, 200 mg twice daily for
6–12 months and some authors advocate 200 mg 3 times a day for the
ﬁrst 3 days. Fluconazole is less eﬀective than itraconazole and it's
considered to be a second-line agent [1,10].
Despite the rarity of the disease in Europe, clinicians should be
aware of the possibility of histoplasmosis in cases of tonsillar ulceration
specially in travelers or immigrants from sub-Saharan West and central
Africa.
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